目的：掌握我院心血管系统药物的应用状况及发展趋势，引导临床合理用药。
OBJECTIVE: to understand the current situation and developing trend of drugs used for cardiovascular diseases and to guide rational drug use in clinic.
摘要：心血管系统药物是临床常用药，中毒危害大，可出现顽固性休克及心脏骤停。
Abstract: Cardiovascular drugs are commonly used in clinical medicine, which can cause refractory shock and cardiac arrest when poisoning.
对此作用进行研究具有非常重要的临床意义。本文就食物对心血管系统药物作用的影响加以综述。
Great clinical importance to study these interactions for a comprehensive understanding of food on the actions of cardiovascular agents, is presented here in this article.
结论临床心血管系统药物应用基本合理，对于疗效显著、不良反应轻微、价格合理的药物患者依从性好，临床使用广泛。
Conclusion The use of cardiovascular drugs is rational in our hospital. The safe and effective drugs with reasonable price and better compliance are widely applied.
研究证实，通过联合生活方式和对抗心血管系统疾病的药物治疗，可以减少超过50%的心脏病发生的危险。
Research has proven that the risk of heart disease can be reduced by more than 50% through a combination of lifestyle approaches and medications that protect against cardiovascular disease.
结果含乌头碱类药物致不良反应共653例，主要涉及神经和心血管系统，主要表现为各种类型心律失常。
RESULTS: a total of 653 aconitine induced ADR cases were found, involving mainly the nervous system and the cardiovascular system, with arrhythmias of different types as the main symptom.
致死病例35例(5.4%)，致死药物亦以心血管系统用药居首位。
There were 35 (5.4%) fatal cases mainly caused by cardiovascular system drugs.
第一项研究是一项数据库分析，发现同时服用吡氯格雷和PPI药物的患者心血管系统发病增加，另一项称作CREDO的研究没发现联合用药有副作用。
The first study, a database analysis, found an increase in cardiac events in patients taking clopidogrel and a PPI. A second study, called CREDO, found no adverse effects from the combination.
目前一些药物的心血管系统保护和肾脏保护的特点部分是源于其对PAI - 1活性的抑制作用。
The cardioprotective and renoprotective properties of some currently available drugs might be attributable in part to inhibition of PAI-1.
在736例喹诺酮类药物ADR中，以神经系统损害最多，其次是光毒性、消化系统损害、心血管系统损害等；
In 736 ADR cases reports of quinolone antibacterial agents, the nervous system was the most damage, followed by light toxicity, digestive system damage and cardiovascular system damage.
详细论述了心血管药物、抗感染药、中枢神经系统药物、消化性溃疡药物、抗肿瘤药和药物新剂型的研究现状及动态，以及这几类药物市场的前景预测。
The current situation and trends of cardiovasculars, anti-infectives, CNS drugs, anti-ulcers, anti-cancers and new formulations as well as market prediction were also described.
Brennan告诉Bloomberg，目前，他的公司主要是经营针对于呼吸系统疾病、炎症、感染、心血管疾病和肿瘤的试验性药物。
Brennan told Bloomberg that his company is now in the market for experimental drugs for respiratory problems, inflammation, infections, cardiovascular disease and cancer.
Brennan告诉Bloomberg，目前，他的公司主要是经营针对于呼吸系统疾病、炎症、感染、心血管疾病和肿瘤的试验性药物。
Brennan told Bloomberg that his company is now in the market for experimental drugs for respiratory problems, inflammation, infections, cardiovascular disease and cancer.
应用推荐